Literature DB >> 28438501

Fatigue in COPD: an important yet ignored symptom.

Martijn A Spruit1, Jan H Vercoulen2, Mirjam A G Sprangers3, Emiel F M Wouters4.   

Abstract

Mesh：

Year:  2017        PMID： 28438501     DOI： 10.1016/S2213-2600(17)30158-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  14 in total

1.  Relationship between perceived and neuromuscular fatigue in COPD patients with chronic respiratory failure with long-term oxygen therapy: a cross-sectional study.

Authors:  Mara Paneroni; Michele Vitacca; Laura Comini; Beatrice Salvi; Manuela Saleri; Federico Schena; Massimo Venturelli
Journal:  Eur J Appl Physiol       Date:  2022-08-11       Impact factor: 3.346

2.  Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis.

Authors:  Maarten Van Herck; Jeanine Antons; Jan H Vercoulen; Yvonne M J Goërtz; Zjala Ebadi; Chris Burtin; Daisy J A Janssen; Melissa S Y Thong; Jacqueline Otker; Arnold Coors; Mirjam A G Sprangers; Jean W M Muris; Judith B Prins; Martijn A Spruit; Jeannette B Peters
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

3.  Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation.

Authors:  Yvonne M J Goërtz; Martijn A Spruit; Alex J Van 't Hul; Jeannette B Peters; Maarten Van Herck; Nienke Nakken; Remco S Djamin; Chris Burtin; Melissa S Y Thong; Arnold Coors; Yvonne Meertens-Kerris; Emiel F M Wouters; Judith B Prins; Frits M E Franssen; Jean W M Muris; Lowie E G W Vanfleteren; Mirjam A G Sprangers; Daisy J A Janssen; Jan H Vercoulen
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

4.  Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis.

Authors:  Ada E M Bloem; Rémy L M Mostard; Naomi Stoot; Jan H Vercoulen; Jeannette B Peters; Daisy J A Janssen; Jan W H Custers; Martijn A Spruit
Journal:  J Clin Med       Date:  2020-04-20       Impact factor: 4.241

5.  Enhance Access to Pulmonary Rehabilitation with a Structured and Personalized Home-Based Program-reabilitAR: Protocol for Real-World Setting.

Authors:  Sarah Bernard; Rui Vilarinho; Inês Pinto; Rosa Cantante; Ricardo Coxo; Rosa Fonseca; Sagrario Mayoralas-Alises; Salvador Diaz-Lobato; João Carvalho; Cátia Esteves; Cátia Caneiras
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

6.  Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study.

Authors:  Yvonne M J Goërtz; Milou Looijmans; Judith B Prins; Daisy J A Janssen; Melissa S Y Thong; Jeannette B Peters; Chris Burtin; Yvonne Meertens-Kerris; Arnold Coors; Jean W M Muris; Mirjam A G Sprangers; Emiel F M Wouters; Jan H Vercoulen; Martijn A Spruit
Journal:  BMJ Open       Date:  2018-04-10       Impact factor: 2.692

7.  Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial.

Authors:  Philip C Calder; Alessandro Laviano; Fredrik Lonnqvist; Maurizio Muscaritoli; Maria Öhlander; Annemie Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-09-10       Impact factor: 12.910

Review 8.  Fatigue in Chronic Respiratory Diseases: Theoretical Framework and Implications For Real-Life Performance and Rehabilitation.

Authors:  Mathieu Gruet
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

9.  The COPD Assessment Test (CAT) can screen for fatigue among patients with COPD.

Authors:  Caroline Stridsman; My Svensson; Viktor Johansson Strandkvist; Linnea Hedman; Helena Backman; Anne Lindberg
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

10.  Perceptions towards physical activity in adult lung transplant recipients with cystic fibrosis.

Authors:  Martina Wietlisbach; Christian Benden; Angela Koutsokera; Kathleen Jahn; Paola M Soccal; Thomas Radtke
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.